NASDAQ: CMND - Clearmind Medicine Inc.

Yield per half year: -1.32%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Clearmind Medicine Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company has a collaboration with Clearmind Medicine Inc. to conduct a study evaluating the companies combination treatment for obesity and metabolic syndrome. The company was formerly known as Cyntar Ventures Inc.

more details
and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-08-16
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета cad
Сайт https://www.clearmindmedicine.com
Цена ао 1.24
Change price per day: -3.85% (1.56)
Change price per week: +25% (1.2)
Change price per month: +17.19% (1.28)
Change price per 3 month: +20.01% (1.2499)
Change price per half year: -1.32% (1.52)
Change price per year: -46.62% (2.81)
Change price per 3 year: 0% (1.5)
Change price per 5 year: 0% (1.5)
Change price per 10 year: 0% (1.5)
Change price per year to date: +17.19% (1.28)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 1.48 9
P/E 0 0
EV/EBITDA 0.4714 10
Total: 4.88

Efficiency

Title Value Grade
ROA, % -195.31 0
ROE, % -1182.27 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 8173.57 10
Yield EPS, % 21338.9 10
Total: 8
More

Institutions Volume Share, %
AdvisorShares Investments, LLC 4109 0.68
Geode Capital Management, LLC 2119 0.35
Susquehanna International Group, LLP 1658 0.27
Citadel Advisors Llc 490 0.08



Head Job title Payment Year of birth
Dr. Adi Zuloff-Shani Ph.D. Chief Executive Officer N/A 1969 (56 years)
Mr. Alan Mark Rootenberg B.Com., B.Comm, C.A., CPA Chief Financial Officer N/A 1952 (73 years)
Mr. Gilad Babchuk Head of Strategy & Communication N/A
Prof. Mark Haden M.S.W. Vice President of Business Development N/A 1955 (70 years)

Address: Canada, Vancouver, 1220 West 6th Avenue - open in Google maps, open in Yandex maps
Website: https://www.clearmindmedicine.com